A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis

  • Teh, Tse-Chieh (Primary Chief Investigator (PCI))
  • Slade, Charlotte (Chief Investigator (CI))
  • Bird, Robert J (Chief Investigator (CI))
  • Barnes, Sara (Chief Investigator (CI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date30/11/2131/12/26

Keywords

  • Haematology
  • Mastocytosis
  • Clinical trial